On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for their COVID-19 laboratory developed test (LDT) with the option of using home-collected saliva samples for COVID-19 testing. The test had been previously added to the high complexity molecular-based LDT ﾓumbrellaﾔ EUA, to permit testing of samples self-collected by patients at home using the Spectrum Solutions LLC SDNA-1000 Saliva Collection Device.